US 9458215
Compositions and methods for osteogenic gene therapy
granted A61KA61K38/1825A61P
Quick answer
US patent 9458215 (Compositions and methods for osteogenic gene therapy) held by The United States of America as represented by the Department of Veteran Affairs expires Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America as represented by the Department of Veteran Affairs
- Grant date
- Tue Oct 04 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 29 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61K, A61K38/1825, A61P, A61P19/08, A61P19/10